Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The vaginal microbiome in reproductive age women

ABSTRACT: The vaginal microbiome in reproductive age women

PROVIDER: PRJNA575586 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR11232400_1.fastq.gz	Fastqsanger.gz
	SRR11232400_2.fastq.gz	Fastqsanger.gz
	SRR11232700_1.fastq.gz	Fastqsanger.gz
	SRR11232700_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 1959

Similar Datasets

The vaginal microbiome in reproductive age women

Project description:The vaginal microbiome in reproductive age women

| PRJNA575585 | ENA

vaginal microbe of women within the reproductive age

Project description:vaginal microbe of women within the reproductive age Raw sequence reads

| PRJNA1056286 | ENA

Diverse vaginal microbiomes in reproductive-age women with vulvovaginal candidiasis

Project description:Diverse vaginal microbiomes in reproductive-age women with vulvovaginal candidiasis

| PRJEB4606 | ENA

Healthy and Diseased Vaginal Microbiome within Pregnant and Non-Pregnant Reproductive-Age Women in Egypt

Project description:Healthy and Diseased Vaginal Microbiome within Pregnant and Non-Pregnant Reproductive-Age Women in Egypt

| PRJNA616364 | ENA

Healthy and Diseased Vaginal Microbiome within Pregnant and Non-Pregnant Reproductive-Age Women in Egypt

Project description:Healthy and Diseased Vaginal Microbiome within Pregnant and Non-Pregnant Reproductive-Age Women in Egypt

| PRJNA616046 | ENA

vaginal microbiome for pregnant women

Project description:vaginal microbiome for pregnant women

| PRJNA488871 | ENA

Global Expression of Molecular Transporters in the Human Vaginal Tract

Project description:Pre-exposure chemoprophylaxis using antiretroviral agents is a promising strategy for the prevention of sexual HIV transmission in women. Molecular transporters in the human vaginal tract may play a pivotal role in determining drug disposition and, consequently, pharmacodynamic outcomes in these efforts. Little is known, however, on the expression of these transporters in vaginal tissues, representing a critical knowledge gap. Our study analyzed the genome-wide transcriptome in 44 vaginal tissue samples from 6 reproductive-age women undergoing gynecologic surgeries. The genome-wide transcriptome in 44 vaginal tissue samples from 6 reproductive-age women (20-56 years old) undergoing gynecologic surgeries was measured.

2014-01-29 | E-GEOD-49892 | biostudies-arrayexpress

Vaginal epithelial gene expression in postmenopausal women suffering from vaginal dryness

Project description:The onset of menopause is accompanied by a dramatic increase in reported symptoms of vaginal dryness, soreness, irritation or itching, pain with intercourse and bleeding after intercourse. Collectively these affect 25-50% of women of post-menopausal age and significantly impact their quality of life. To examine how gene expression differs between these groups, surface vaginal epithelial cells were collected from postmenopausal women suffering from vaginal dryness and appropriate controls not suffering from dryness. Affymetrix GeneChip Human 1.0 ST microarrays were performed on RNA isolated from ten participants.

2011-11-12 | GSE26761 | GEO

The Dynamics of the Vaginal Microbiome During Infertility Therapy with In Vitro Fertilization-Embryo Transfer

Project description:Clinical treatment protocols for infertility with in vitro fertilization-embryo transfer (IVF-ET) provide a unique opportunity to assess the human vaginal microbiome in defined hormonal milieu. Herein, we have investigated the association of circulating ovarian-derived estradiol (E2) and progesterone (P4) concentrations to the vaginal microbiome. Thirty IVF-ET patients were enrolled in this study, after informed consent. Blood was drawn at four time points during the IVF-ET procedure. In addition, if a pregnancy resulted, blood was drawn at 4-to-6 weeks of gestation. The serum concentrations of E2 and P4 were measured. Vaginal swabs were obtained in different hormonal milieu. Two independent genome-based technologies (and the second assayed in two different ways) were employed to identify the vaginal microbes. The vaginal microbiome underwent a transition with a decrease in E2 (and/or a decrease in P4). Novel bacteria were found in the vagina of 33% of the women undergoing IVF-ET. Our approach has enabled the discovery of novel, previously unidentified bacterial species in the human vagina in different hormonal milieu. While the relationship of hormone concentration and vaginal microbes was found to be complex, the data support a shift in the microbiome of the human vagina during IVF-ET therapy using standard protocols. The data also set the foundation for further studies examining correlations between IVF-ET outcome and the vaginal microbiome within a larger study population.

2011-10-24 | E-MEXP-2958 | biostudies-arrayexpress

Vaginal epithelial gene expression in postmenopausal women suffering from vaginal dryness

2011-11-12 | E-GEOD-26761 | biostudies-arrayexpress